Novavax NVAX Transition Services — Deferred Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's transition services — deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's transition services — deferred revenue?
- Novavax (NVAX) reported transition services — deferred revenue of $2.5M in Q1 2026.
- How has Novavax's transition services — deferred revenue changed year-over-year?
- Novavax's transition services — deferred revenue decreased by 88.1% year-over-year, from $21M to $2.5M.
- What does transition services — deferred revenue mean?
- Deferred revenue represents payments received from customers for transition services that have not yet been earned through the delivery of performance obligations. It serves as a liability on the balance sheet that will be recognized as revenue in future periods as services are fulfilled. Monitoring this balance provides insight into the company's future revenue visibility and the pace of service delivery.